LIVER CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s Liver Cancer News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.

November 13, 2018

Keytruda Immunotherapy for Treatment of Liver Cancer

By Anonymous User Anonymous User

According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment for advanced liver cancer in patients who have already been treated with Nexavar (sorafenib), (1) and has not been approved by the US for use in patients with liver cancer. Keytruda was approved as a […]

View full entry

Tags: Liver Cancer, News Tips and Features, News Tips and Features Other


August 20, 2018

FDA Approves Lenvatinib for Treatment of Advanced Hepatocellular Cancer

By Anonymous User Anonymous User

The U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA® (lenvatinib) for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). This approval was based on results from REFLECT, where LENVIMA demonstrated a proven treatment effect on overall survival as well as statistically significant superiority and clinically meaningful improvements in progression-free survival […]

View full entry

Tags: Liver Cancer, News Tips and Features, News Tips and Features Other


July 12, 2018

Cyramza Improves Survival in Poor-Prognosis Liver Cancer

By Anonymous User Anonymous User

Andrew X. Zhu, MD, PhD, director of Liver Cancer Research at Massachusetts General Hospital presented new data at the 2018 World Congress on Gastrointestinal Cancer (WCGC) demonstrating that Cyramza (ramucirumab) significantly improves survival in a subset of patients with hepatocellular carcinoma (HCC) who have high levels of the plasma protein α-fetoprotein (AFP), which is associated […]

View full entry

Tags: cyramza, hepatocellular cancer treatment, Liver Cancer, News Tips and Features, News Tips and Features Other


Cabometyx™ May Be 'New Treatment Option' for Liver Cancer

February 20, 2018

Cabometyx™ May Be ‘New Treatment Option’ for Liver Cancer

By Anonymous User Anonymous User

CancerConnect News:  Treatment with Cabometyx  (cabozantinib) significantly improved outcomes in patients with advanced hepatocellular carcinoma (HCC), leading researchers to suggest that it could offer a new treatment option for this patient population.  The new findings come from the phase 3 CELESTIAL trial and were presented at the 2018 Gastrointestinal Cancers Symposium.1 About Liver Cancer Liver […]

View full entry

Tags: Cabometyx, cabozantinib, hepatocellular cancer, Liver Cancer, News Tips and Features, News Tips and Features Other


Keytruda Immunotherapy Appears Active for Treatment of Liver Cancer

February 15, 2018

Keytruda Immunotherapy Appears Active for Treatment of Liver Cancer

By Anonymous User Anonymous User

CancerConnect News:  According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment for advanced liver cancer in patients who have already been treated with Nexavar (sorafenib).1 About Liver Cancer Liver cancer, or hepatocellular carcinoma (HCC), is the second most common cause of cancer-related deaths worldwide.2,3 […]

View full entry

Tags: checkpoint inhibitor, hepatocellular cancer, immunotherapy, keytruda, Liver Cancer, News Tips and Features, News Tips and Features Other, pembrolizumab, Precision Cancer Medicine


Opdivo Precision Cancer Medicine Improves Outcomes in Advanced Liver Cancer

May 18, 2017

Opdivo Precision Cancer Medicine Improves Outcomes in Advanced Liver Cancer

By Anonymous User Anonymous User

Results from the CheckMate 040 clinical trial have been recently reported and found that Opdivo (nivolumab), an immuno-oncology drug which acts by modulating the immune system, produces durable responses with long-term survival rates in patients with liver cancer, regardless of whether or not patients were infected with Hepatitis B or C.  These study results were […]

View full entry

Tags: CheckMate 040 nivolumab, immuno-oncology, Liver Cancer, News Tips and Features, News Tips and Features Other, Opdivo, PD-1, Precision Cancer Medicine


First New Drug for Liver Cancer in a Decade: Stivarga

May 8, 2017

First New Drug for Liver Cancer in a Decade: Stivarga

By Anonymous User Anonymous User

The US Food and Drug Administration (FDA) has expanded the indication for Stivarga (regorafenib) to now include treatment for patients with hepatocellular carcinoma (HCC) who have previously been treated with the drug Nexavar. Expansion of Stivarga, ‘s indication marks the first FDA-approved treatment for a liver cancer in almost a decade. Stivarga is an oral […]

View full entry

Tags: immunotherapy, Liver Cancer, News Tips and Features, News Tips and Features Other, regorafenib, Stivarga


Managing Your Finances in the Face of Illness

September 27, 2016

Managing Your Finances in the Face of Illness

By megm megm

Monitoring the financial transactions that accompany any medical challenge can require vigilance, but the long-term benefit of remaining financially secure is worth the extra effort. By Sarah O’Leary When you are in the throes of a major medical event, the last thing you want to do is manage the quality and the price of your […]

View full entry

Tags: anal fissures, Barrett's Esophagus Esophageal Cancer, Celiac Disease, cirrhosis, Colon Cancer, crohns disease ulcerative colitis, Esophageal Cancer, Gallbladder and Bile Duct Cancer, gallstones, Gastric Cancer, gastric Ulcer, GERD


View more articles like this
More news and in-depth Colon Cancer information

CONDITIONS OF THE GI TRACT